Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.44 |
| ▸ | CA2 | P00918 | 3/20 | 0.44 |
| ▸ | CA7 | P43166 | 2/20 | 0.44 |
| ▸ | CA9 | Q16790 | 2/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA4 | P22748 | 1/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.37 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17529726 | 0.85 | CA1 (0.44) | CA1CA2CA7CA9CA12 | |
| SCHEMBL7088869 | 0.81 | TAAR1 (0.31) | ALDH1A1TSHRTDP1HPGDL3MBTL1 | |
| SCHEMBL17529813 | 0.78 | CA1 (0.41) | CA1CA2CA7CA9CA12 | |
| SCHEMBL17529686 | 0.78 | CA1 (0.50) | CA1CA2CA7CA9CA12 | |
| SCHEMBL14809988 | 0.75 | CYBB (0.33) | ALDH1A1TP53TSHRKMT2AMAPK1 | |
| SCHEMBL4608738 | 0.74 | LMNA (0.33) | ALDH1A1TP53TSHRHPGDKMT2A | |
| SCHEMBL11461077 | 0.74 | CA1 (0.46) | CA1CA2CA7CA9CA12 | |
| SCHEMBL17529691 | 0.74 | CA1 (0.46) | CA1CA2CA7CA9CA12 | |
| SCHEMBL11318865 | 0.74 | CA1 (0.50) | CA1CA2CA7CA9CA12 | |
| SCHEMBL17529811 | 0.74 | ACHE (0.38) | CA1CA2CA7CA9ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2990112-B1 | METHOD FOR MANUFACTURING CATALYST FOR SYNTHESIZING CYCLIC CARBONATE | MARUZEN PETROCHEM CO LTD (JP) | 2020-03-25 | — | — | EP | disclosed |
| EP-2990113-B1 | METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS | MARUZEN PETROCHEM CO LTD (JP) | 2020-03-25 | — | — | EP | disclosed |
| US-10029241-B2 | Method for producing catalyst for cyclic carbonate synthesis | MARUZEN PETROCHEMICAL CO., LTD. (JP) | 2018-07-24 | — | — | US | disclosed |
| US-10011621-B2 | Method for producing silica gel-immobolized phosphonium salt catalysts | MARUZEN PETROCHEMICAL CO., LTD. (JP) | 2018-07-03 | — | — | US | disclosed |
| CN-105163853-B | The manufacturing method of cyclic carbonate catalyst for synthesizing | 丸善石油化学株式会社 | 2018-06-12 | — | — | CN | disclosed |
| US-9834536-B2 | Method for producing catalyst for cyclic carbonate synthesis | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2017-12-05 | — | — | US | disclosed |
| CN-105121013-B | The manufacture method of cyclic carbonate catalyst for synthesizing | 丸善石油化学株式会社 | 2017-10-20 | — | — | CN | disclosed |
| US-20160108071-A1 | METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS | MARUZEN PETROCHEMICAL CO., LTD. (JP) | 2016-04-21 | — | — | US | disclosed |
| US-20160067695-A1 | METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS | MARUZEN PETROCHEMICAL CO., LTD. (JP) | 2016-03-10 | — | — | US | disclosed |
| US-20160060242-A1 | METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2016-03-03 | — | — | US | disclosed |
| EP-2990114-A1 | METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS | National Institute of Advanced Industrial Science and Technology (JP) | 2016-03-02 | — | — | EP | disclosed |
| EP-2990112-A1 | METHOD FOR MANUFACTURING CATALYST FOR SYNTHESIZING CYCLIC CARBONATE | Maruzen Petrochemical Co., Ltd. (JP) | 2016-03-02 | — | — | EP | disclosed |
| EP-2990113-A1 | METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS | Maruzen Petrochemical Co., Ltd. (JP) | 2016-03-02 | — | — | EP | disclosed |
| CN-105163853-A | Method for manufacturing catalyst for synthesizing cyclic carbonate | MARUZEN PETROCHEM CO LTD | 2015-12-16 | — | — | CN | disclosed |
| CN-105163854-A | Method for producing catalyst for synthesizing cyclic carbonate | NAT INST OF ADVANCED IND SCIEN | 2015-12-16 | — | — | CN | disclosed |
| CN-105121013-A | Method for producing catalyst for cyclic carbonate synthesis | MARUZEN PETROCHEM CO LTD | 2015-12-02 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160067695-A1 | METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS | CYCS, CA7, CA9 | CA1 15/4885CA2 10/4885CA7 2/4885 |
| US-10029241-B2 | Method for producing catalyst for cyclic carbonate synthesis | CYCS, CA7, CA9 | CA1 15/4885CA2 10/4885CA7 2/4885 |
| US-20160108071-A1 | METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS | EPHX2, CA4, CA9 | CA1 79/4885CA2 11/4885CA7 9/4885 |
| US-20160060242-A1 | METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS | CA2, PLCB3, PHOSPHO1 | CA1 28/4885CA2 1/4885CA7 8/4885 |
| US-10011621-B2 | Method for producing silica gel-immobolized phosphonium salt catalysts | SIK2, SIK3, SIK1 | CA1 148/4885CA2 87/4885CA7 482/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.